Emerald Advisers’s Loxo Oncology, Inc LOXO Stock Holding History

Emerald Advisers’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-154,416	Closed	-$21.6M	–	276
2018 Q4	$21.6M	Buy	154,416 +36,166	+31%	+$5.49M	1.06%	34
2018 Q3	$20.2M	Buy	118,250 +25,020	+27%	+$4.2M	0.74%	56
2018 Q2	$16.2M	Buy	+93,230	New	+$14M	0.61%	80

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Emerald Advisers's LOXO Position: Q1 2019 in Review

Emerald Advisers sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 154,416 shares — an estimated $21.6M sold.

Emerald Advisers first reported a position in LOXO in Q2 2018 and held it in 3 quarters. The position peaked at $21.6M in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Emerald Advisers reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Emerald Advisers sold 154,416 Loxo Oncology, Inc shares in Q1 2019, an estimated $21.6M.
Emerald Advisers first reported a position in Loxo Oncology, Inc in Q2 2018 and held it in 3 quarters.
Emerald Advisers's Loxo Oncology, Inc position peaked at $21.6M in Q4 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Emerald Advisers's 13F filing for Q1 2019, filed 1 May 2019.